DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a hold rating to a buy rating in a research note released on Wednesday morning.

Other research analysts have also recently issued reports about the stock. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a report on Monday, July 22nd. Barrington Research restated an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, October 25th. Finally, Stifel Nicolaus dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a research note on Thursday, July 18th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Moderate Buy" and a consensus target price of $31.88.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded up $0.59 during midday trading on Wednesday, hitting $23.98. The stock had a trading volume of 3,979,007 shares, compared to its average volume of 2,958,303. The company has a market capitalization of $4.86 billion, a PE ratio of -27.79, a P/E/G ratio of 1.27 and a beta of 1.02. DENTSPLY SIRONA has a 1 year low of $22.84 and a 1 year high of $37.60. The stock has a 50 day moving average price of $25.00 and a two-hundred day moving average price of $26.06. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. lifted its stake in DENTSPLY SIRONA by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier's stock worth $1,328,000 after purchasing an additional 3,219 shares during the last quarter. Nordea Investment Management AB lifted its position in shares of DENTSPLY SIRONA by 6.7% in the 1st quarter. Nordea Investment Management AB now owns 83,898 shares of the medical instruments supplier's stock worth $2,784,000 after buying an additional 5,288 shares during the last quarter. Daiwa Securities Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 7.9% in the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier's stock valued at $585,000 after buying an additional 1,296 shares during the period. Central Pacific Bank Trust Division bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $64,000. Finally, GSA Capital Partners LLP bought a new position in DENTSPLY SIRONA in the first quarter worth about $655,000. Institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.